Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Hilpert

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Journal of Cancer Research and Clinical Oncology|February 2, 2006
Optimizing the use of aromatase inhibitors in adjuvant therapy for postmenopausal patients with hormone-responsive early breast cancer: current and future prospectsWalter Jonat, Felix Hilpert
Expert Review of Anticancer Therapy|September 19, 2018
Patient-reported outcomes in ovarian cancer: are they key factors for decision making?Felix Hilpert, Andreas Du Bois
Cancer Chemotherapy and Pharmacology|November 8, 2005
The use of aromatase inhibitors in adjuvant therapy for early breast cancerWalter Jonat, Felix Hilpert, Nicolai Maass
Expert Opinion on Drug Safety|March 21, 2007
Aromatase inhibitors: a safety comparisonWalter Jonat, Felix Hilpert, Manfred Kaufmann
Onkologie|June 13, 2009
[Evaluating treatment from the point of view of the patient -PROs (patient-reported outcomes)]Inge Bördlein-Wahl, Felix Hilpert, Thomas Kohlmann
Scientific Reports|August 15, 2018
Comparative analysis of surface coating properties of five hydrophobins from Aspergillus nidulans and Trichoderma reseeiLex Winandy, Felix Hilpert, Oleksandra Schlebusch, et al.
Onkologie|March 15, 2012
Treatment of elderly ovarian cancer patients in the context of controlled clinical trials: a joint analysis of the AGO Germany experienceFelix Hilpert, Pauline Wimberger, Andreas du Bois, et al.
Archives of Gynecology and Obstetrics|December 25, 2010
Congenital retroperitoneal vascular anomalies: impact on pelvic surgeryAlexander Strauss, Carolin Kuemper, Christoph Mundhenke, et al.
Journal of Neuro-Oncology|August 8, 2002
Docetaxel-induced nail changes--a neurogenic mechanism: a case reportGunnar Wasner, Felix Hilpert, Jörn Schattschneider, et al.
Journal of Analytical Toxicology|May 21, 2005
Simultaneous congener-specific determination of selected organochlorine compounds and nitro musks in human whole blood samples by solid-phase extraction and capillary gas chromatography with electron capture detectionMaret Bauer, Felix Hilpert, Norbert Arnold, et al.
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Journal of Cancer Research and Clinical Oncology|February 2, 2006
Optimizing the use of aromatase inhibitors in adjuvant therapy for postmenopausal patients with hormone-responsive early breast cancer: current and future prospectsWalter Jonat, Felix Hilpert
Expert Review of Anticancer Therapy|September 19, 2018
Patient-reported outcomes in ovarian cancer: are they key factors for decision making?Felix Hilpert, Andreas Du Bois
Cancer Chemotherapy and Pharmacology|November 8, 2005
The use of aromatase inhibitors in adjuvant therapy for early breast cancerWalter Jonat, Felix Hilpert, Nicolai Maass
Expert Opinion on Drug Safety|March 21, 2007
Aromatase inhibitors: a safety comparisonWalter Jonat, Felix Hilpert, Manfred Kaufmann
Onkologie|June 13, 2009
[Evaluating treatment from the point of view of the patient -PROs (patient-reported outcomes)]Inge Bördlein-Wahl, Felix Hilpert, Thomas Kohlmann
Scientific Reports|August 15, 2018
Comparative analysis of surface coating properties of five hydrophobins from Aspergillus nidulans and Trichoderma reseeiLex Winandy, Felix Hilpert, Oleksandra Schlebusch, et al.
Onkologie|March 15, 2012
Treatment of elderly ovarian cancer patients in the context of controlled clinical trials: a joint analysis of the AGO Germany experienceFelix Hilpert, Pauline Wimberger, Andreas du Bois, et al.
Archives of Gynecology and Obstetrics|December 25, 2010
Congenital retroperitoneal vascular anomalies: impact on pelvic surgeryAlexander Strauss, Carolin Kuemper, Christoph Mundhenke, et al.
Journal of Neuro-Oncology|August 8, 2002
Docetaxel-induced nail changes--a neurogenic mechanism: a case reportGunnar Wasner, Felix Hilpert, Jörn Schattschneider, et al.
Journal of Analytical Toxicology|May 21, 2005
Simultaneous congener-specific determination of selected organochlorine compounds and nitro musks in human whole blood samples by solid-phase extraction and capillary gas chromatography with electron capture detectionMaret Bauer, Felix Hilpert, Norbert Arnold, et al.
Pageof 11